FDA issues updated birth-control pill information

On April 10, the U.S. Food and Drug Administration (FDA) issued an update on blood clots and birth control pills containing drospirenone. The update states that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. Read more and see a list of drospirenone-containing products here.

Related Articles:

Leave a Reply

You have to agree to the comment policy.


Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing